Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*

Summary

The bill lets licensed health‑care providers prescribe Schedule II controlled substances through telemedicine or telehealth when a proper provider‑patient relationship exists. It applies to any New Jersey provider using real‑time or reviewed asynchronous technology and adds patient‑notification, record‑review, and follow‑up requirements. The change aims to expand access to needed medications while keeping safety standards comparable to in‑person care.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share